Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Apr 02, 2026
XCF Global (SAFX): +104% Surge in 30 Days Amid Capital Raise and Merger Momentum

XCF Global (SAFX): +104% Surge in 30 Days Amid Capital Raise and Merger Momentum

Key Takeaways

  • SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress.
  • Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
  • Key drivers include shareholder approval for share issuance, facility upgrades for sustainable aviation fuel (SAF) production, and binding merger term sheet.
  • High volatility characterized both periods, with March seeing sharp swings tied to news flow.
  • Macro tailwinds from rising SAF prices due to global supply disruptions boosted sentiment.

Understanding XCF Global (SAFX) and Its Place in Renewables

XCF Global, Inc. (SAFX) is a renewable fuels company focused on producing sustainable aviation fuel (SAF) and biofuels. Headquartered in Houston, Texas, and founded in 2016, the firm develops and operates clean fuel production facilities, including its flagship New Rise Reno refinery in Nevada. In my view, XCF Global positions itself as an early mover in the U.S. SAF market, targeting net-zero emissions in aviation through scalable production.

In the competitive utilities-renewable industry, SAFX differentiates via proprietary technology like Axens’ Vegan hydrotreating for flexible feedstocks. Its business model emphasizes partnerships, capital raises, and mergers to expand capacity amid growing demand for low-carbon fuels. Recent financing and operational upgrades align with these fundamentals, supporting the stock's recovery as investor confidence builds in SAF's long-term role. One thing that stands out is how these developments fit into broader sector trends.

SAFX Stock Performance: Breaking Down the Last 30 Days and Quarter

Over the last 30 days, SAFX stock climbed from a close of approximately $0.18 to $0.37, marking a +104% gain. The movement was highly volatile and trend-driven, with intraday swings exceeding 20% on multiple days amid news catalysts. Volume spiked significantly, reflecting heightened trader interest.

For the past quarter, the stock advanced +44% from around $0.26 to $0.37. Performance featured early dips, mid-quarter spikes to near $0.50, and range-bound action lately. Trading well below the 50-day moving average ($0.24) but above recent lows, SAFX showed resilience in a volatile micro-cap environment. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Key Catalysts Behind SAFX's 30-Day Rally

The 30-day rally stemmed primarily from company-specific developments. On March 10, XCF announced stockholder approval at a March 6 special meeting for issuing over 19.99% of outstanding shares to EEME Energy SPV I LLC, unlocking the remaining $6.2 million of a $10 million private placement. This funds upgrades at the New Rise Reno facility, including new hydrotreating catalysts for broader SAF production.

Progress on a January binding term sheet for a three-party merger with Southern Energy Renewables and DevvStream fueled optimism, promising an integrated SAF platform with environmental credits. CEO comments at the ABLC2026 conference highlighted renewable energy security amid Middle East conflicts spiking SAF prices to record highs, enhancing market sentiment.

These factors drove sharp intraday gains, like a 12% rally on conference hype, outweighing dilution concerns from the raise. From what I see, this news flow has been the clear driver.

Quarterly Performance Drivers for SAFX

The quarterly uptrend built on sustained merger and financing narratives. The January 26 binding term sheet with Southern and DevvStream targeted a $3 billion enterprise value, sparking initial spikes. Ongoing capital infusion addressed operational needs, while plant conversion advanced SAF output.

Macro factors included global jet fuel disruptions elevating SAF premiums, underscoring domestic production's appeal. Institutional behavior via EEME's commitment signaled backing, countering earlier Nasdaq bid price deficiency risks from December 2025 lows. Cumulative impacts from these positioned SAFX for growth in renewables amid regulatory tailwinds for low-carbon aviation fuels. This is important because it highlights resilience amid volatility.

Trending AI Robots

In my research workflow, I often turn to Tickeron’s Trending AI Robots page, which showcases the platform's top-performing AI trading bots from hundreds available. These bots scan thousands of tickers across strategies like swing trading, day trading, and long-term investing. They're curated based on recent performance metrics, win rates, average returns, and relevance to current market trends, helping me identify automated tools with a proven edge. Varying by timeframe, risk profile, and asset focus, they offer backtested signals and real-time alerts. I find it useful to explore this page for bots tailored to my style, as it enhances my stock analysis process.

What to Watch Next for SAFX Investors

Investors should monitor merger closing timelines with Southern Energy Renewables and DevvStream, including definitive agreements and regulatory nods. Upcoming facility upgrades at New Rise Reno, funded by the $10 million raise, will signal production ramp-up progress. I’m watching this closely, as it could be a key indicator.

Sector trends in SAF demand, influenced by aviation decarbonization mandates and policy incentives, remain key. Macro conditions like fuel price volatility from geopolitical tensions could sway sentiment. Nasdaq compliance with the $1.00 bid price rule through June 2026 warrants attention, alongside any earnings releases or SEC filings on financing.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: SAFT

SAFT in +0.33% Uptrend, advancing for three consecutive days on October 02, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SAFT advanced for three days, in 168 of 310 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In 68 of 192 cases where SAFT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 35%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 29 of 52 cases where SAFT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 56%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SAFT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.

SAFT broke above its upper Bollinger Band on October 01, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.734) is normal, around the industry mean (1.992). P/E Ratio (22.277) is within average values for comparable stocks, (14.718). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (3.303). Dividend Yield (0.036) settles around the average of (0.019) among similar stocks. P/S Ratio (1.192) is also within normal values, averaging (1.594).

The Tickeron Profit vs. Risk Rating rating for this company is 30 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 57, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. SAFT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 78 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Industry description

Property and casualty companies insure against accidents of non-physical harm, such as lawsuits, damage to personal assets, car crashes and more. Progressive Corporation, Travelers Companies, Inc. and Allstate Corporation are some of the biggest providers of such products.

Market Cap

The average market capitalization across the Property/Casualty Insurance Industry is 12.9B. The market cap for tickers in the group ranges from 0 to 127.84B. CB holds the highest valuation in this group at 127.84B. The lowest valued company is FXFLF at 0.

High and low price notable news

The average weekly price growth across all stocks in the Property/Casualty Insurance Industry was 2%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 12%. HIPO experienced the highest price growth at 5%, while STC experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Property/Casualty Insurance Industry was 2%. For the same stocks of the Industry, the average monthly volume growth was 21% and the average quarterly volume growth was 8%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 63
Price Growth Rating: 54
SMR Rating: 69
Profit Risk Rating: 57
Seasonality Score: 40 (-100 ... +100)
View a ticker or compare two or three
SAFT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of private passenger automobile insurance services

Industry PropertyCasualtyInsurance

Industry
Property Or Casualty Insurance
Address
20 Custom House Street
Phone
+1 617 951-0600
Employees
568
Web
https://www.safetyinsurance.com
Interact to see
Advertisement
United Therapeutics Corporation focuses on biotechnology innovations for chronic and life-threatening conditions, particularly in pulmonary diseases. The company's portfolio centers on treatments for pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF), featuring products like Tyvaso (treprostinil inhalation solution), Orenitram (oral treprostinil), Remodulin, and Adcirca.
WVE stock plunged approximately -52% over the past 30 days, driven primarily by disappointing high-dose data from the Phase 1 INLIGHT trial of obesity candidate WVE-007 on March 26, which erased prior gains from positive initial results. Over the past quarter, shares declined around -61%, reflecting high volatility in biotech sentiment amid clinical trial outcomes and broader sector pressures on clinical-stage firms
KOD stock surged +39% over the past 30 days, driven primarily by positive Phase 3 GLOW2 trial results for Zenkuda in diabetic retinopathy. Over the past quarter, shares gained +36%, reflecting anticipation of clinical catalysts and a successful $184 million capital raise.
Roblox Corporation (RBLX) runs a platform where millions of users create and dive into immersive 3D experiences. The business centers on a virtual economy: users buy Robux for in-game items, and creators cash out through the developer exchange (DevEx) program. In the online gaming space, Roblox stands out as a metaverse pioneer, going up against the likes of Epic Games' Fortnite and newer AI-driven platforms. The fundamentals reflect impressive user growth—daily active users (DAUs) reached 144 million in Q4 2025, a 69% jump year-over-year—but ongoing net losses underscore the heavy spending on infrastructure, AI, and safety. From what I see, this tension between growth and profitability has fueled much of the recent volatility in RBLX shares, as investors weigh strong engagement against shrinking margins.
Megan Holdings Limited (MGN) is a Malaysia-based company focused on the development, construction, maintenance, and upgrade of aquaculture and agriculture farms, along with related services. At its core, the business provides end-to-end solutions for shrimp farms, from design and building hatcheries to ongoing maintenance. It operates mainly in Sabah, Malaysia, across segments like aquaculture/agriculture, industrial solutions such as smart technologies, and investments in marketable securities.
Megan Holdings Limited (MGN), based in Kuala Lumpur and founded in 2020, focuses on developing, constructing, maintaining, and upgrading aquaculture and agriculture farms in Malaysia. The company operates in three segments—aquaculture and agriculture, industrial solutions like supplying smart technologies and machinery rentals, and investments in marketable securities—carving out a niche in engineering and construction within the Industrials sector. Its subsidiary status under Star Sprite Limited adds a layer of operational stability.
Pony AI Inc. (PONY) stands out as a leading player in autonomous mobility, dedicated to bringing self-driving technology to commercial use. Founded in 2016 and based in Guangzhou, China, the company operates across China, the U.S., and other international markets, offering robotaxi services, robotruck logistics, and licensing for intelligent driving solutions. Its business model leans heavily on asset-light partnerships with original equipment manufacturers (OEMs), transportation network companies (TNCs), and logistics platforms.
Maze Therapeutics, Inc. (MAZE) is a clinical-stage biopharmaceutical company focused on developing small-molecule precision medicines for kidney and metabolic diseases. In my view, the company's core strength lies in its proprietary Maze Compass platform, which uses human genetics and variant functionalization to identify and advance therapies targeting genetically defined patient populations.
In my view, JPM stands out as the largest U.S. bank by assets and market capitalization, commanding leading market shares across key segments. It holds approximately 11.1% of U.S. retail deposits, 23.6% of credit card sales volume, 8.4% of global investment banking fees, 11.8% of markets revenue, and 10% of treasury services revenue. This diversified "universal banking model" spans consumer and community banking, commercial and investment banking, and asset and wealth management, generating resilient revenue streams.
In recent sessions, WMT has held steady around $124, pulling back from February highs near $134. From what I see, this resilience stands out as the stock has outperformed broader indices year-to-date, thanks to its defensive role in groceries and essentials. Shoppers are leaning toward value options, and consistent volumes show ongoing institutional support. The premium valuation reflects confidence in Walmart's omnichannel progress and market share gains. Even with macro headwinds, I view WMT as a portfolio staple during uncertain times.
I've been following ANTX, a biopharmaceutical company based in Menlo Park, California, that develops novel small molecule therapeutics from its proprietary boron chemistry platform. The focus is on underserved areas like infectious diseases, with the lead candidate epetraborole advancing in Phase 3 trials for non-tuberculous mycobacterial (NTM) lung disease and acute melioidosis. The pipeline also includes AN2-502998 for chronic Chagas disease in preclinical stages, along with programs in oncology.
Tilly's, Inc. (TLYS) operates as a specialty retailer specializing in casual apparel, footwear, accessories, and hardgoods aimed at young men, women, boys, and girls. The company focuses on branded fashion inspired by action sports, surf, and skate culture, offering products like tops, bottoms, swimwear, backpacks, hats, and sunglasses from well-known brands such as Vans and Hurley. With approximately 223 stores in malls and lifestyle centers, complemented by e-commerce through www.tillys.com, Tilly's effectively combines physical and digital sales channels.
NKE shares are tumbling approximately 11% in premarket trading on April 1, 2026, sliding to near nine-year lows after the previous close of $52.82. The primary catalyst is Nike's weak Q4 fiscal 2026 guidance: management projected a 2%–4% revenue decline, sharply missing analyst expectations of approximately 1.9% growth.
Aemetis, Inc. (AMTX) is a renewable natural gas and renewable fuels company focused on developing and commercializing low- and negative-carbon intensity products that replace petroleum-based fuels. The company operates through segments including California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. Its core business model centers on converting agricultural waste—such as dairy manure into biogas and corn/wood waste into ethanol—into high-value biofuels like renewable natural gas (RNG), ethanol, biodiesel, and sustainable aviation fuel precursors.
Silvaco Group, Inc. (SVCO) provides technology computer-aided design (TCAD) software, electronic design automation (EDA) software, and semiconductor intellectual property (SIP) solutions. The company helps semiconductor and photonics firms design, simulate, and optimize processes from atomic-level modeling to complex system-on-chip (SoC) development. Its business centers on licensing software tools and IP blocks, along with engineering services, targeting high-growth areas like AI, power devices, automotive, foundries, and 5G/6G mobile.
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
APTV shares are tumbling approximately 14% in premarket trading on April 1, 2026, representing one of the sharpest single-session losses in the stock's recent history. The primary catalyst is Aptiv's Board of Directors formally approving the long-anticipated spin-off of its Electrical Distribution Systems (EDS) business, now named Versigent, combined with the announcement of a $1.6 billion private offering of senior notes tied to the transaction.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.